Search by Drug Name or NDC

    NDC 72578-0065-14 Ranolazine 1000 mg/1 Details

    Ranolazine 1000 mg/1

    Ranolazine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Viona Pharmaceuticals Inc. The primary component is RANOLAZINE.

    Product Information

    NDC 72578-0065
    Product ID 72578-065_2c72dbc3-5385-4706-b5fd-841d4b70a26f
    Associated GPIs 32200040007430
    GCN Sequence Number 062973
    GCN Sequence Number Description ranolazine TAB ER 12H 1000 MG ORAL
    HIC3 A2C
    HIC3 Description ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC
    GCN 98733
    HICL Sequence Number 033446
    HICL Sequence Number Description RANOLAZINE
    Brand/Generic Generic
    Proprietary Name Ranolazine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranolazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 1000
    Active Ingredient Units mg/1
    Substance Name RANOLAZINE
    Labeler Name Viona Pharmaceuticals Inc
    Pharmaceutical Class Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210188
    Listing Certified Through 2024-12-31

    Package

    NDC 72578-0065-14 (72578006514)

    NDC Package Code 72578-065-14
    Billing NDC 72578006514
    Package 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-14)
    Marketing Start Date 2019-09-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.34116
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description RANOLAZINE ER 1,000 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis